X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
index medicus (23) 23
immunology (22) 22
allergy (21) 21
allergy and immunology (17) 17
mastocytosis (15) 15
female (14) 14
mutation (14) 14
spanish network (14) 14
male (13) 13
adult (11) 11
aged (11) 11
middle aged (11) 11
abridged index medicus (9) 9
bone marrow (9) 9
mast cell disease (9) 9
proto-oncogene proteins c-kit - genetics (9) 9
anaphylaxis (8) 8
flow cytometry (8) 8
mast cells - immunology (8) 8
mastocytosis, systemic - diagnosis (8) 8
animals (7) 7
criteria (7) 7
mastocytosis, systemic - immunology (7) 7
studies (7) 7
systemic mastocytosis (7) 7
adolescent (6) 6
classification (6) 6
kit mutation (6) 6
mast cell (6) 6
patients (6) 6
anaphylaxis - immunology (5) 5
mast cells (5) 5
mast cells - pathology (5) 5
mast-cells (5) 5
prognosis (5) 5
treatment outcome (5) 5
tryptase levels (5) 5
urticaria pigmentosa (5) 5
venom (5) 5
young adult (5) 5
aged, 80 and over (4) 4
allergies (4) 4
arthropod venoms - immunology (4) 4
biopsy (4) 4
bone-marrow (4) 4
c-kit (4) 4
diagnosis (4) 4
flow-cytometric analysis (4) 4
hymenoptera - immunology (4) 4
immunotherapy (4) 4
mastocytosis, systemic - blood (4) 4
mastocytosis, systemic - genetics (4) 4
mastocytosis, systemic - pathology (4) 4
rema (4) 4
serum tryptase (4) 4
tryptase (4) 4
tryptases - blood (4) 4
age (3) 3
anaphylaxis - diagnosis (3) 3
bone marrow examination (3) 3
cutaneous mastocytosis (3) 3
hymenoptera (3) 3
immunoglobulin e - blood (3) 3
immunophenotype (3) 3
immunophenotyping (3) 3
indolent systemic mastocytosis (3) 3
mast cells - physiology (3) 3
mast-cell disease (3) 3
mast-cell disorders (3) 3
mastocytosis - immunology (3) 3
mastocytosis, cutaneous - diagnosis (3) 3
mastocytosis, cutaneous - immunology (3) 3
mastocytosis, systemic - drug therapy (3) 3
mutation - genetics (3) 3
pathology (3) 3
predictive value of tests (3) 3
proteins (3) 3
research (3) 3
risk factors (3) 3
skin (3) 3
spain (3) 3
venom immunotherapy (3) 3
activation syndromes (2) 2
acute myeloid-leukemia (2) 2
adults (2) 2
anaphylaxis - complications (2) 2
anaphylaxis - therapy (2) 2
anti-allergic agents - therapeutic use (2) 2
biology (2) 2
biomarkers - blood (2) 2
bone marrow - metabolism (2) 2
bone marrow - pathology (2) 2
bone marrow cells - immunology (2) 2
bone marrow cells - pathology (2) 2
care and treatment (2) 2
catalytic domain (2) 2
cd25 (2) 2
cd25 antigen (2) 2
cell lineage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 137, Issue 1, pp. 35 - 45
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 131, Issue 4, pp. 1213 - 1224.e4
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 125, Issue 6, pp. 1269 - 1278.e2
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 133, Issue 2, pp. 520 - 528.e5
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2009, Volume 124, Issue 3, pp. 514 - 521
Background Indolent systemic mastocytosis is a group of rare diseases for which reliable predictors of progression and outcome are still lacking. Objective... 
Allergy and Immunology | Mastocytosis | indolent systemic mastocytosis | long-term prognosis | CRITERIA | RESPONSIVENESS | TRYPTASE LEVELS | CATALYTIC DOMAIN | C-KIT | HEMATOLOGIC DISORDER | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | MAST-CELL DISEASE | ALLERGY | MUTATION | IMATINIB | Multivariate Analysis | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Proto-Oncogene Proteins c-kit - immunology | Recombinant Proteins | Proto-Oncogene Proteins c-kit - metabolism | Enzyme Inhibitors - administration & dosage | Young Adult | beta 2-Microglobulin - blood | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Retrospective Studies | Enzyme Inhibitors - adverse effects | Mast Cells - immunology | Antiviral Agents - therapeutic use | Mastocytosis, Systemic - drug therapy | Interferon-alpha - therapeutic use | Hydroxyurea - administration & dosage | Antiviral Agents - administration & dosage | Enzyme Inhibitors - therapeutic use | Disease Progression | Interferon-alpha - administration & dosage | Hydroxyurea - adverse effects | Mastocytosis, Systemic - mortality | Antiviral Agents - adverse effects | Adolescent | Mastocytosis, Systemic - pathology | Hydroxyurea - therapeutic use | Aged | Interferon-alpha - adverse effects | Medicine, Experimental | Medical research | Development and progression | Mast cell disease | Leukemia | Heart attacks | Medical imaging | Disease | Multivariate analysis | Patients | Studies | Osteoporosis | Biopsy | Medical prognosis | Classification | Tomography | Mutation | Age | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 137, Issue 1, pp. 168 - 178.e1
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2008, Volume 121, Issue 2, pp. 519 - 526
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2012, Volume 131, Issue 2, pp. 614 - 615
  Conversely, they did not screen for mastocytosis in their series, and the potential association between the absence of hives during anaphylaxis and... 
Allergy and Immunology | IMMUNOLOGY | ALLERGY | SPANISH NETWORK | MAST-CELL DISORDERS | Arthropod Venoms - immunology | Hymenoptera - immunology | Animals | Anaphylaxis - etiology | Humans | Female | Male | Cardiovascular Agents - adverse effects | Studies | Medical research
Journal Article